Zhongming Dai1,2, Shufang Wang1, Weiping Zhang3, Yunsheng Yang4. 1. Department of Digestive Disease, PLA General Hospital, Beijing, 100853, People's Republic of China. 2. Department of Digestive Disease, Xinjiang Military Region General Hospital, Urumuqi, 830000, Xinjiang Province, People's Republic of China. 3. Department of Digestive Disease, Suzhou BenQ Hospital, Suzhou, 215000, Jiangsu Province, People's Republic of China. 4. Department of Digestive Disease, PLA General Hospital, Beijing, 100853, People's Republic of China. yangyunsheng321@163.com.
Abstract
BACKGROUND: The replication protein A3 (RPA3) is a component of the RPA protein complex, which plays an essential role in multiple processes of DNA metabolism. AIMS: However, the involvement of RPA3 in gastric cancer tumorigenesis has not yet been investigated. METHODS: We stably knocked down RPA3 expression using short hairpin RNA in AGS cell line, and performed cell growth, colony formation and soft agar assays. Xenograft experiments were performed to examine tumor promoting properties of RPA3 in vivo. The qRT-PCR and immunohistochemistry were performed to evaluate RPA3 expression levels in 37 and 12 pairs of gastric cancer patient samples, respectively. Association between RPA3 expression and survival was evaluated in an independent cohort of 85 gastric cancer patients. RESULTS: Downregulation of RPA3 inhibited cell growth, clonogenicity and soft agar growth in AGS cells. Decreased expression of RPA3 significantly reduced tumor growth rate in AGS xenografts. In addition, RPA3 was upregulated in cancerous tissues compared with matched noncancerous adjacent tissues in gastric cancer patients. High expression of RPA3 was associated with poor patient survival. CONCLUSION: Upregulation of RPA3 is involved in gastric cancer tumorigenesis and is associated with poorer patient survival. RPA3 represents a new therapeutic target of gastric cancer and serves as a potential prognostic biomarker for patient survival in gastric cancer.
BACKGROUND: The replication protein A3 (RPA3) is a component of the RPA protein complex, which plays an essential role in multiple processes of DNA metabolism. AIMS: However, the involvement of RPA3 in gastric cancer tumorigenesis has not yet been investigated. METHODS: We stably knocked down RPA3 expression using short hairpin RNA in AGS cell line, and performed cell growth, colony formation and soft agar assays. Xenograft experiments were performed to examine tumor promoting properties of RPA3 in vivo. The qRT-PCR and immunohistochemistry were performed to evaluate RPA3 expression levels in 37 and 12 pairs of gastric cancerpatient samples, respectively. Association between RPA3 expression and survival was evaluated in an independent cohort of 85 gastric cancerpatients. RESULTS: Downregulation of RPA3 inhibited cell growth, clonogenicity and soft agar growth in AGS cells. Decreased expression of RPA3 significantly reduced tumor growth rate in AGS xenografts. In addition, RPA3 was upregulated in cancerous tissues compared with matched noncancerous adjacent tissues in gastric cancerpatients. High expression of RPA3 was associated with poor patient survival. CONCLUSION: Upregulation of RPA3 is involved in gastric cancer tumorigenesis and is associated with poorer patient survival. RPA3 represents a new therapeutic target of gastric cancer and serves as a potential prognostic biomarker for patient survival in gastric cancer.
Authors: C R Wobbe; L Weissbach; J A Borowiec; F B Dean; Y Murakami; P Bullock; J Hurwitz Journal: Proc Natl Acad Sci U S A Date: 1987-04 Impact factor: 11.205
Authors: Elena Bochkareva; Lilia Kaustov; Ayeda Ayed; Gwan-Su Yi; Ying Lu; Antonio Pineda-Lucena; Jack C C Liao; Andrei L Okorokov; Jo Milner; Cheryl H Arrowsmith; Alexey Bochkarev Journal: Proc Natl Acad Sci U S A Date: 2005-10-17 Impact factor: 11.205
Authors: Christopher Greenman; Philip Stephens; Raffaella Smith; Gillian L Dalgliesh; Christopher Hunter; Graham Bignell; Helen Davies; Jon Teague; Adam Butler; Claire Stevens; Sarah Edkins; Sarah O'Meara; Imre Vastrik; Esther E Schmidt; Tim Avis; Syd Barthorpe; Gurpreet Bhamra; Gemma Buck; Bhudipa Choudhury; Jody Clements; Jennifer Cole; Ed Dicks; Simon Forbes; Kris Gray; Kelly Halliday; Rachel Harrison; Katy Hills; Jon Hinton; Andy Jenkinson; David Jones; Andy Menzies; Tatiana Mironenko; Janet Perry; Keiran Raine; Dave Richardson; Rebecca Shepherd; Alexandra Small; Calli Tofts; Jennifer Varian; Tony Webb; Sofie West; Sara Widaa; Andy Yates; Daniel P Cahill; David N Louis; Peter Goldstraw; Andrew G Nicholson; Francis Brasseur; Leendert Looijenga; Barbara L Weber; Yoke-Eng Chiew; Anna DeFazio; Mel F Greaves; Anthony R Green; Peter Campbell; Ewan Birney; Douglas F Easton; Georgia Chenevix-Trench; Min-Han Tan; Sok Kean Khoo; Bin Tean Teh; Siu Tsan Yuen; Suet Yi Leung; Richard Wooster; P Andrew Futreal; Michael R Stratton Journal: Nature Date: 2007-03-08 Impact factor: 49.962
Authors: Yun-Miao Guo; Jie-Rong Chen; Yan-Chun Feng; Melvin L K Chua; Yanni Zeng; Edwin Pun Hui; Allen K C Chan; Lin-Quan Tang; Lin Wang; Qian Cui; Hui-Qiong Han; Chun-Ling Luo; Guo-Wang Lin; Yan Liang; Yang Liu; Zhong-Lian He; Yu-Xiang Liu; Pan-Pan Wei; Chu-Jun Liu; Wan Peng; Bo-Wei Han; Xiao-Yu Zuo; Enya H W Ong; Eugenia L L Yeo; Kar Perng Low; Gek San Tan; Tony K H Lim; Jacqueline S G Hwang; Bo Li; Qi-Sheng Feng; Xiaojun Xia; Yun-Fei Xia; Josephine Ko; Wei Dai; Maria L Lung; Anthony T C Chan; Dennis Y M Lo; Mu-Sheng Zeng; Hai-Qiang Mai; Jianjun Liu; Yi-Xin Zeng; Jin-Xin Bei Journal: Adv Sci (Weinh) Date: 2020-03-20 Impact factor: 16.806
Authors: Dai Zhang; Si Yang; Yiche Li; Jia Yao; Jian Ruan; Yi Zheng; Yujiao Deng; Na Li; Bajin Wei; Ying Wu; Zhen Zhai; Jun Lyu; Zhijun Dai Journal: JAMA Netw Open Date: 2020-10-01